April 2011
QS/1 Helps Report PSE Sales to State of Kansas
Spartanburg, SC – April 22, 2011 – QS/1 is helping Kansas pharmacies report sales of cold and allergy medications to the state. Beginning April 29, 2011, Kansas pharmacies that sell medications containing ephedrine, pseudoephedrine, and/or phenylpropanolamine products must comply with a new law that requires real-time PSE reporting to the state. This electronic monitoring program helps officials in the state of Kansas track illegal PSE purchases.
